Previous close | 52.69 |
Open | 52.70 |
Bid | 55.00 |
Ask | 57.90 |
Strike | 380.00 |
Expiry date | 2025-01-17 |
Day's range | 52.69 - 52.70 |
Contract range | N/A |
Volume | |
Open interest | 224 |
On May 2, 2024, Director Sangeeta Bhatia sold 467 shares of Vertex Pharmaceuticals Inc (NASDAQ:VRTX) as reported in a recent SEC Filing.
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $400.16, representing a -0.49% change from its previous close.
Arcus Biosciences (RCUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.